Species differences in stereoselective hydrolase activity in intestinal mucosa

被引:24
作者
Yoshigae, Y
Imai, T
Horita, A
Matsukane, H
Otagiri, M
机构
[1] Kumamoto Univ, Fac Pharmaceut Sci, Kumamoto 862, Japan
[2] Japanese Red Cross Kumamoto Hosp, Kumamoto 862, Japan
关键词
O-acyl-propranolol; stereoselective hydrolysis; intestinal mucosa; carboxylesterase;
D O I
10.1023/A:1011946314416
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The aim of this study is to investigate species differences in the stereoselective hydrolysis for propranolol ester prodrugs in mammalian intestinal mucosa and Caco-2 cells. Methods. Hydrolase activities for propranolol prodrugs and p-nitrophenylacetate in man (age: 51-71 years), the beagle dog (age: 4 years) and Wistar rat (age: 8 weeks) intestinal mucosa, and also in Caco-2 cells (passage between 60-70) were estimated by determining the rate of production of propranolol and p-nitrophenol, respectively. Results. The hydrolase activities for both propranolol prodrugs and p-nitrophenylacetate were in the order of man > rat >> Caco-2 cells > dog for intestinal microsomes, and rat > Caco-2 cells is approximately equal to man > dog for intestinal cytosol. Dog microsomes showed stereoselective hydrolysis for propranolol prodrugs, but not those from human or rat. Interestingly, both subcellular fractions of Caco-2 cells showed remarkable R-enantioselectivity except acetyl propranolol. Enzyme kinetic experiments for each enantiomer of butyryl propranolol in microsomes revealed that dog possesses both low and high affinity hydrolases. Both Km and Vmax values in rat were largest among examined microsomes, while Vmax/Km was largest in man. Finally, it was shown that the carboxylesterases might contribute to the hydrolysis of propranolol prodrug in all species by inhibition experiments. Conclusions. The hydrolase activities for propranolol prodrugs and p-nitrophenylacetate in intestinal mucosa showed great species differences and those in human intestine were closer to those of rat intestine than dog intestine or Caco-2 cells.
引用
收藏
页码:626 / 631
页数:6
相关论文
共 24 条
[11]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[12]   PURIFICATION AND CHARACTERIZATION OF 2 RAT-LIVER MICROSOMAL CARBOXYLESTERASES (HYDROLASE-A AND HYDROLASE-B) [J].
MORGAN, EW ;
YAN, BF ;
GREENWAY, D ;
PETERSEN, DR ;
PARKINSON, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 315 (02) :495-512
[13]   REGULATION OF 2 RAT-LIVER MICROSOMAL CARBOXYLESTERASE ISOZYMES - SPECIES-DIFFERENCES, TISSUE DISTRIBUTION, AND THE EFFECTS OF AGE, SEX, AND XENOBIOTIC TREATMENT OF RATS [J].
MORGAN, EW ;
YAN, BF ;
GREENWAY, D ;
PARKINSON, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 315 (02) :513-526
[14]   ESTERASE-ACTIVITY TOWARD THE DIASTEREOMERS OF CEFUROXIME AXETIL IN THE RAT AND DOG [J].
MOSHER, GL ;
MCBEE, J ;
SHAW, DB .
PHARMACEUTICAL RESEARCH, 1992, 9 (05) :687-689
[15]  
Prueksaritanont T, 1996, DRUG METAB DISPOS, V24, P634
[16]   In vivo assessment of intestinal, hepatic, and pulmonary first pass metabolism of propofol in the rat [J].
Raoof, AA ;
Augustijns, PF ;
Verbeeck, RK .
PHARMACEUTICAL RESEARCH, 1996, 13 (06) :891-895
[17]   Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption [J].
Ribadeneira, MD ;
Aungst, BJ ;
Eyermann, CJ ;
Huang, SM .
PHARMACEUTICAL RESEARCH, 1996, 13 (02) :227-233
[18]   Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver [J].
Schwer, H ;
Langmann, T ;
Daig, R ;
Becker, A ;
Aslanidis, C ;
Schmitz, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (01) :117-120
[19]   AN INVITRO AND INVIVO CORRELATIVE APPROACH TO THE EVALUATION OF ESTER PRODRUGS TO IMPROVE ORAL DELIVERY OF PROPRANOLOL [J].
SHAMEEM, M ;
IMAI, T ;
OTAGIRI, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (04) :246-252
[20]   STEREOSELECTIVE HYDROLYSIS OF O-ISOVALERYL PROPRANOLOL AND ITS INFLUENCE ON THE CLEARANCE OF PROPRANOLOL AFTER ORAL-ADMINISTRATION [J].
SHAMEEM, M ;
IMAI, T ;
YOSHIGAE, Y ;
SPARREBOOM, A ;
OTAGIRI, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (12) :1754-1757